The biotech industry promises solid prospects with continuous innovation and sustained demand for advanced healthcare solutions. An aging population, growing lifestyle diseases, and the need for high-quality treatments for rare and common conditions support the optimism around the industry’s long-term growth.
Therefore, it might be wise to invest in fundamentally strong biotech stocks Innoviva, Inc. (INVA), Puma Biotechnology, Inc. (PBYI), and Shionogi & Co., Ltd. (SGIOY).
